News

European Hypertension Guidelines Fill US Void

Author and Disclosure Information

 

EXPERT ANALYSIS FROM THE ESC CONGRESS 2013

Dr. Smith and Dr. Williams said that they had no relevant disclosures. Dr. Mancia said that he has been a consultant to 14 drug and device companies. Dr. Renata Cífková said that she had been a consultant to Daiichi Sankyo, Teva, Zentiva, Merck Sharpe and Dohme, Actavis, Berlin Chemie, Boehringer Ingelheim, and Bayer. Dr. Marx said that he has been a consultant to 13 drug and device companies. Dr. Williams said that he has been a consultant to Pfizer, Merck, Sanofi-BMS, and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Think exercise first for secondary prevention?
Type 2 Diabetes ICYMI
Type 2 diabetes encompasses three distinct subtypes
Type 2 Diabetes ICYMI
Drug combo tops sequential therapy in new-onset diabetes
Type 2 Diabetes ICYMI
Bariatric surgery cuts long-term diabetes complications
Type 2 Diabetes ICYMI
Adjuvant gemcitabine a plus for resected pancreatic cancer
Type 2 Diabetes ICYMI
Type 2 diabetes encompasses three distinct subtypes
Type 2 Diabetes ICYMI
Think Exercise First for Secondary Prevention?
Type 2 Diabetes ICYMI
USPSTF: No Evidence for Routine Blood Pressure Screening in Children
Type 2 Diabetes ICYMI
Be Assertive When Tackling Smoking, Obesity, Etc
Type 2 Diabetes ICYMI
Drug Combo in New-onset Diabetes
Type 2 Diabetes ICYMI